{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T02:22:28Z","timestamp":1767838948803,"version":"3.49.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.imlet.2018.03.012","type":"journal-article","created":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T12:29:40Z","timestamp":1522153780000},"page":"26-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Novel intranasal pertussis vaccine based on bacterium-like particles as a mucosal adjuvant"],"prefix":"10.1016","volume":"198","author":[{"given":"Wei","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiming","family":"Kou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiheng","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunlai","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.imlet.2018.03.012_bib0005","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S1286-4579(01)01421-6","article-title":"Immunity to bordetella pertussis","volume":"3","author":"Mills","year":"2001","journal-title":"Microbes Infect."},{"issue":"2","key":"10.1016\/j.imlet.2018.03.012_bib0010","first-page":"100","article-title":"Pertussis in infants and the resurgence of a vaccine preventable disease: what to do? Commentary","volume":"53","author":"Fedele","year":"2017","journal-title":"Ann. Ist. Super. Sanita"},{"key":"10.1016\/j.imlet.2018.03.012_bib0015","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/978-1-4615-3410-5_30","article-title":"Laboratory correlates of protection and protective immunity to Bordetella pertussis","volume":"327","author":"Shahin","year":"1992","journal-title":"Adv. Exp. Med. Biol."},{"issue":"8","key":"10.1016\/j.imlet.2018.03.012_bib0020","doi-asserted-by":"crossref","first-page":"ftv071","DOI":"10.1093\/femspd\/ftv071","article-title":"Waning and aging of cellular immunity to Bordetella pertussis","volume":"73","author":"van Twillert","year":"2015","journal-title":"Pathog. Dis."},{"issue":"12","key":"10.1016\/j.imlet.2018.03.012_bib0025","first-page":"1","article-title":"What is wrong with pertussis vaccine immunity? inducing and recalling vaccine-Specific immunity","volume":"9","author":"Eberhardt","year":"2017","journal-title":"Cold Spring Harbor Perspect. Inbiol."},{"issue":"3","key":"10.1016\/j.imlet.2018.03.012_bib0030","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/infdis\/161.3.480","article-title":"Widespread silent transmission of pertussis in families: antibody correlates of infection and symptomatology","volume":"161","author":"Long","year":"1990","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.imlet.2018.03.012_bib0035","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1093\/infdis\/160.5.838","article-title":"Serum IgG, IgA, and IgM responses to pertussis toxin, filamentous hemagglutinin, and agglutinogens 2 and 3 after infection with Bordetella pertussis and immunization with whole-cell pertussis vaccine","volume":"160","author":"Thomas","year":"1989","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.imlet.2018.03.012_bib0040","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0264-410X(94)90112-0","article-title":"New strategies for using mucosal vaccination to achieve","volume":"12","author":"Walker","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.imlet.2018.03.012_bib0045","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1034\/j.1600-065X.2000.917304.x","article-title":"The innate immune response of the respiratory epithelium","volume":"173","author":"Diamond","year":"2000","journal-title":"Immunol. Rev."},{"issue":"11","key":"10.1016\/j.imlet.2018.03.012_bib0050","doi-asserted-by":"crossref","first-page":"6883","DOI":"10.4049\/jimmunol.0901466","article-title":"What role does the route of immunization play in the generation of protective immunity against mucosal pathogens?","volume":"183","author":"Belyakov","year":"2009","journal-title":"J. Immunol. (Baltimore, Md.: 1950)"},{"issue":"7","key":"10.1016\/j.imlet.2018.03.012_bib0055","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1371\/journal.ppat.0020065","article-title":"Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough","volume":"2","author":"Mielcarek","year":"2006","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.imlet.2018.03.012_bib0060","doi-asserted-by":"crossref","first-page":"e83449","DOI":"10.1371\/journal.pone.0083449","article-title":"A phase I clinical study of a live attenuated Bordetella pertussis vaccine\u2013BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers","volume":"9","author":"Thorstensson","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.imlet.2018.03.012_bib0065","series-title":"Glutaraldehyde and Formalin Detoxified Bordetella Toxin Vaccine","author":"Capiau","year":"1996"},{"issue":"6","key":"10.1016\/j.imlet.2018.03.012_bib0070","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3109\/10611869609015965","article-title":"Nasal delivery of vaccines","volume":"3","author":"Almeida","year":"1996","journal-title":"J. Drug Target."},{"issue":"2","key":"10.1016\/j.imlet.2018.03.012_bib0075","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.imlet.2014.01.006","article-title":"New advances in mucosal vaccination","volume":"161","author":"Ranasinghe","year":"2014","journal-title":"Immunol. Lett."},{"issue":"11\u201312","key":"10.1016\/j.imlet.2018.03.012_bib0080","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0264-410X(02)00516-9","article-title":"Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant","volume":"21","author":"Isaka","year":"2003","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.imlet.2018.03.012_bib0085","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4161\/hv.22755","article-title":"A CpG-containing oligodeoxynucleotide adjuvant for acellular pertussis vaccine improves the protective response againstBordetella pertussis","volume":"9","author":"Asokanathan","year":"2014","journal-title":"Hum. Vaccines Immunotherapeutics"},{"issue":"2","key":"10.1016\/j.imlet.2018.03.012_bib0090","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ymeth.2005.09.015","article-title":"Mucosal vaccine delivery of antigens tightly bound to an adjuvant particle made from food-grade bacteria","volume":"38","author":"van Roosmalen","year":"2006","journal-title":"Methods"},{"issue":"2","key":"10.1016\/j.imlet.2018.03.012_bib0095","doi-asserted-by":"crossref","first-page":"e55472","DOI":"10.1371\/journal.pone.0055472","article-title":"Activated human nasal epithelial cells modulate specific antibody response against bacterial or viral antigens","volume":"8","author":"Yeh","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.imlet.2018.03.012_bib0100","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3389\/fimmu.2013.00282","article-title":"Bacterium-like particles for efficient immune stimulation of existing vaccines and new subunit vaccines in mucosal applications","volume":"4","author":"Van Braeckel-Budimir","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2018.03.012_bib0105","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.imlet.2017.05.003","article-title":"Systemic and mucosal immune responses elicited by intranasal immunization with a pneumococcal bacterium-like particle-based vaccine displaying pneumolysin mutant Plym2","volume":"187","author":"Lu","year":"2017","journal-title":"Immunol. Lett."},{"issue":"2","key":"10.1016\/j.imlet.2018.03.012_bib0110","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/mi.2009.131","article-title":"Neonatal mucosal immunization with a non-living, non-genetically modified Lactococcus lactis vaccine carrier induces systemic and local Th1-type immunity and protects against lethal bacterial infection","volume":"3","author":"Ramirez","year":"2010","journal-title":"Mucosal Immunol."},{"issue":"18","key":"10.1016\/j.imlet.2018.03.012_bib0115","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1016\/j.vaccine.2006.02.040","article-title":"Immunogenicity of a malaria parasite antigen displayed by Lactococcus lactis in oral immunisations","volume":"24","author":"Ramasamy","year":"2006","journal-title":"Vaccine"},{"issue":"13","key":"10.1016\/j.imlet.2018.03.012_bib0120","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1016\/j.vaccine.2006.09.026","article-title":"Development of lactococcal GEM-based pneumococcal vaccines","volume":"25","author":"Audouy","year":"2007","journal-title":"Vaccine"},{"issue":"26","key":"10.1016\/j.imlet.2018.03.012_bib0125","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.1016\/j.vaccine.2006.03.054","article-title":"Lactococcus lactis GEM particles displaying pneumococcal antigens induce local and systemic immune responses following intranasal immunization","volume":"24","author":"Audouy","year":"2006","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.imlet.2018.03.012_bib0130","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1128\/JB.05184-11","article-title":"Complete genome sequence of Bordetella pertussis CS, a Chinese pertussis vaccine strain","volume":"193","author":"Zhang","year":"2011","journal-title":"J. Bacteriol."},{"issue":"11\u201312","key":"10.1016\/j.imlet.2018.03.012_bib0135","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.vaccine.2003.09.040","article-title":"Rapid purification of pertussis toxin (PT) and filamentous hemagglutinin (FHA) by cation-exchange chromatography","volume":"22","author":"Ozcengiz","year":"2004","journal-title":"Vaccine"},{"issue":"34","key":"10.1016\/j.imlet.2018.03.012_bib0140","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1016\/j.vaccine.2016.06.029","article-title":"Purification design and practice for pertactin, the third component of acellular pertussis vaccine, from Bordetella pertussis","volume":"34","author":"Li","year":"2016","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.imlet.2018.03.012_bib0145","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1006\/biol.1998.0154","article-title":"WHO guidelines for the production and control of the acellular pertussis component of monovalent or combined vaccines","volume":"26","author":"Arciniega","year":"1998","journal-title":"Biological"},{"issue":"1","key":"10.1016\/j.imlet.2018.03.012_bib0150","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0092-1157(89)90028-0","article-title":"The quantitative assay of the clustering activity of the lymphocytosis-promoting factor (pertussis toxin) of Bordetella pertussis on Chinese hamster ovary (CHO) cells","volume":"17","author":"Fujiwara","year":"1989","journal-title":"J. Biol. Stand."},{"issue":"1","key":"10.1016\/j.imlet.2018.03.012_bib0155","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0092-1157(85)80034-2","article-title":"The standardization of an assay for pertussis toxin and antitoxin in microplate culture of Chinese hamster ovary cells","volume":"13","author":"Gillenius","year":"1985","journal-title":"J. Biol. Stand."},{"issue":"19","key":"10.1016\/j.imlet.2018.03.012_bib0160","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1016\/S0264-410X(99)00037-7","article-title":"Intranasal murine model of Bordetella pertussis infection. I. Prediction of protection in human infants by acellular vaccines","volume":"17","author":"Guiso","year":"1999","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.imlet.2018.03.012_bib0165","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1128\/IAI.66.2.594-602.1998","article-title":"A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis","volume":"66","author":"Mills","year":"1998","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.imlet.2018.03.012_bib0170","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1128\/IAI.01076-08","article-title":"Active and passive immunizations with Bordetella colonization factor A protect mice against respiratory challenge with Bordetella bronchiseptica","volume":"77","author":"Sukumar","year":"2009","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.imlet.2018.03.012_bib0175","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.imlet.2004.10.011","article-title":"Whole-cell pertussis vaccine protects against Bordetella pertussis exacerbation of allergic asthma","volume":"97","author":"Ennis","year":"2005","journal-title":"Immunol. Lett."},{"issue":"9","key":"10.1016\/j.imlet.2018.03.012_bib0180","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1111\/j.1365-2222.2004.02042.x","article-title":"Prior Bordetella pertussis infection modulates allergen priming and the severity of airway pathology in a murine model of allergic asthma","volume":"34","author":"Ennis","year":"2004","journal-title":"Clin. Exp. Allergy"},{"issue":"10","key":"10.1016\/j.imlet.2018.03.012_bib0185","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1586\/14760584.2014.936391","article-title":"Improved pertussis vaccines based on adjuvants that induce cell-mediated immunity","volume":"13","author":"Allen","year":"2014","journal-title":"Expert Rev. Vaccines"},{"issue":"5","key":"10.1016\/j.imlet.2018.03.012_bib0190","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1542\/peds.2011-2594","article-title":"Why do pertussis vaccines fail?","volume":"129","author":"Cherry","year":"2012","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.imlet.2018.03.012_bib0195","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1073\/pnas.1314688110","article-title":"Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model","volume":"111","author":"Warfel","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Suppl. 1","key":"10.1016\/j.imlet.2018.03.012_bib0200","doi-asserted-by":"crossref","first-page":"S167","DOI":"10.1093\/infdis\/165-Supplement_1-S167","article-title":"Humoral immune response patterns of human mucosae: induction and relation to bacterial respiratory tract infections","volume":"165","author":"Brandtzaeg","year":"1992","journal-title":"J. Infect. Dis."},{"issue":"12","key":"10.1016\/j.imlet.2018.03.012_bib0205","doi-asserted-by":"crossref","first-page":"6270","DOI":"10.1128\/IAI.67.12.6270-6280.1999","article-title":"Mutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cells","volume":"67","author":"Ryan","year":"1999","journal-title":"Infect. Immun."},{"issue":"Suppl. 5","key":"10.1016\/j.imlet.2018.03.012_bib0210","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1016\/j.cmi.2016.05.029","article-title":"Live pertussis vaccines: will they protect against carriage and spread of pertussis?","volume":"22","author":"Locht","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"issue":"4","key":"10.1016\/j.imlet.2018.03.012_bib0215","first-page":"274","article-title":"Bordetella pertussis pathogenesis: current and future challenges Nature reviews","volume":"12","author":"Melvin","year":"2014","journal-title":"Microbiology"},{"issue":"11","key":"10.1016\/j.imlet.2018.03.012_bib0220","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.11150\/kansenshogakuzasshi1970.73.1145","article-title":"[Induction of protective immunity for Bordetella pertussis by nasal inoculation of pertussis vaccine in mice]","volume":"73","author":"Ishii","year":"1999","journal-title":"Kansenshogaku Zasshi"},{"issue":"2\u20133","key":"10.1016\/j.imlet.2018.03.012_bib0225","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1574-6968.1993.tb06032.x","article-title":"Mice are protected against Bordetella pertussis infection by intra-nasal immunization with filamentous haemagglutinin","volume":"107","author":"Cahill","year":"1993","journal-title":"FEMS Microbiol. Lett."},{"issue":"1","key":"10.1016\/j.imlet.2018.03.012_bib0230","doi-asserted-by":"crossref","first-page":"75","DOI":"10.7774\/cevr.2015.4.1.75","article-title":"Preliminary study on the immunogenicity of a newly developed GCC Tdap vaccine and its protection efficacy against Bordetella pertussis in a murine intranasal challenge model","volume":"4","author":"Han","year":"2015","journal-title":"Clin. Exp. Vaccine Res."},{"issue":"2","key":"10.1016\/j.imlet.2018.03.012_bib0235","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.biologicals.2013.11.008","article-title":"An international collaborative study of the effect of active pertussis toxin on the modified Kendrick test for acellular pertussis vaccines","volume":"42","author":"Xing","year":"2014","journal-title":"Biologicals"},{"key":"10.1016\/j.imlet.2018.03.012_bib0240","series-title":"Manual for Quality Control of Diphtheria, Tetanus and Pertussis Vaccines","year":"2018"},{"issue":"2","key":"10.1016\/j.imlet.2018.03.012_bib0245","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1128\/IAI.65.2.544-550.1997","article-title":"Intranasal priming with recombinant Bordetella pertussis for the induction of a systemic immune response against a heterologous antigen","volume":"65","author":"Mielcarek","year":"1997","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.imlet.2018.03.012_bib0250","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1128\/IAI.61.2.399-410.1993","article-title":"Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model","volume":"61","author":"Mills","year":"1993","journal-title":"Infect. Immun."},{"issue":"8","key":"10.1016\/j.imlet.2018.03.012_bib0255","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.vaccine.2010.12.083","article-title":"Antibody responses in adult and neonatal BALB\/c mice to immunization with novel Bordetella pertussis vaccine formulations","volume":"29","author":"Gracia","year":"2011","journal-title":"Vaccine"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247817304571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247817304571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T03:37:21Z","timestamp":1604029041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247817304571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":51,"alternative-id":["S0165247817304571"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2018.03.012","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel intranasal pertussis vaccine based on bacterium-like particles as a mucosal adjuvant","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2018.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V. on behalf of European Federation of Immunological Societies.","name":"copyright","label":"Copyright"}]}}